Literature DB >> 12016155

Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice.

David Berrigan1, Susan N Perkins, Diana C Haines, Stephen D Hursting.   

Abstract

Heterozygous p53-deficient (p53(+/-)) mice, a potential model for human Li-Fraumeni Syndrome, have one functional allele of the p53 tumor suppressor gene. These mice are prone to spontaneous neoplasms, most commonly sarcoma and lymphoma; the median time to death of p53+/- mice is 18 months. We have shown previously that juvenile-onset calorie restriction (CR) to 60% of ad libitum (AL) intake delays tumor development in young p53-null (-/-) mice by a p53-independent and insulin-like growth factor 1 (IGF-1)-related mechanism. To determine whether CR is effective when started in adult p53-deficient mice, and to compare chronic CR with an intermittent fasting regimen, male p53+/- mice (7-10 months old, 31-32 mice/group) were randomly assigned to the following regimens: (i) AL (AIN-76A diet), (ii) CR to 60% of AL intake or (iii) 1 day/week fast. Food availability on non-fasting days was controlled to prevent compensatory over feeding. Relative to the AL group, CR significantly delayed (P = 0.001) the onset of tumors in adult mice, whereas the 1 day/week fast caused a moderate delay (P = 0.039). Substantial variation in longevity and maximum body weight within treatments was not correlated with variation in growth characteristics of individual mice. In a separate group of p53+/- mice treated for 4 weeks (n = five mice per treatment), plasma IGF-1 levels in CR versus AL mice were reduced by 20% (P < 0.01) and leptin levels were reduced by 71% (P < 0.01); fasted mice had intermediate levels of leptin and IGF-1. Our findings that CR or a 1 day/week fast suppressed carcinogenesis-even when started late in life in mice predestined to develop tumors due to decreased p53 gene dosage-support efforts to identify suitable interventions influencing energy balance in humans as a tool for cancer prevention.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12016155     DOI: 10.1093/carcin/23.5.817

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  79 in total

Review 1.  Hormone use and abuse: what is the difference between hormones as fountain of youth and doping in sports?

Authors:  A J van der Lely
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

2.  A controlled trial of reduced meal frequency without caloric restriction in healthy, normal-weight, middle-aged adults.

Authors:  Kim S Stote; David J Baer; Karen Spears; David R Paul; G Keith Harris; William V Rumpler; Pilar Strycula; Samer S Najjar; Luigi Ferrucci; Donald K Ingram; Dan L Longo; Mark P Mattson
Journal:  Am J Clin Nutr       Date:  2007-04       Impact factor: 7.045

Review 3.  Calorie restriction in rodents: Caveats to consider.

Authors:  Donald K Ingram; Rafael de Cabo
Journal:  Ageing Res Rev       Date:  2017-06-10       Impact factor: 10.895

4.  Water-only fasting and an exclusively plant foods diet in the management of stage IIIa, low-grade follicular lymphoma.

Authors:  Alan C Goldhamer; Michael Klaper; Afsoon Foorohar; Toshia R Myers
Journal:  BMJ Case Rep       Date:  2015-12-10

Review 5.  Protective effects of short-term dietary restriction in surgical stress and chemotherapy.

Authors:  Sebastian Brandhorst; Eylul Harputlugil; James R Mitchell; Valter D Longo
Journal:  Ageing Res Rev       Date:  2017-02-20       Impact factor: 10.895

Review 6.  Diet, behavior and immunity across the lifespan.

Authors:  Matthew W Hale; Sarah J Spencer; Bruno Conti; Christine L Jasoni; Stephen Kent; Morgan E Radler; Teresa M Reyes; Luba Sominsky
Journal:  Neurosci Biobehav Rev       Date:  2014-12-15       Impact factor: 8.989

Review 7.  Metabolic regulation of Sirtuins upon fasting and the implication for cancer.

Authors:  Yueming Zhu; Yufan Yan; David R Gius; Athanassios Vassilopoulos
Journal:  Curr Opin Oncol       Date:  2013-11       Impact factor: 3.645

8.  C/EBPbeta regulates body composition, energy balance-related hormones and tumor growth.

Authors:  Jennifer Staiger; Mary J Lueben; David Berrigan; Radek Malik; Susan N Perkins; Stephen D Hursting; Peter F Johnson
Journal:  Carcinogenesis       Date:  2008-12-04       Impact factor: 4.944

Review 9.  Oxidative stress and autophagy in cardiac disease, neurological disorders, aging and cancer.

Authors:  Eric E Essick; Flora Sam
Journal:  Oxid Med Cell Longev       Date:  2010 May-Jun       Impact factor: 6.543

10.  Differential impact of tumor suppressor pathways on DNA damage response and therapy-induced transformation in a mouse primary cell model.

Authors:  A Kathleen McClendon; Jeffry L Dean; Adam Ertel; Erik S Knudsen
Journal:  PLoS One       Date:  2010-01-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.